Proteomic analysis identifies novel binding partners of BAP1.
BRCA1-associated protein 1 (BAP1) is a tumor suppressor and its loss can result in mesothelioma, uveal and cutaneous melanoma, clear cell renal cell carcinoma and bladder cancer. BAP1 is a deubiquitinating enzyme of the UCH class that has been implicated in various cellular processes like cell growt...
Guardado en:
Autores principales: | Roy Baas, Fenna J van der Wal, Onno B Bleijerveld, Haico van Attikum, Titia K Sixma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b4f6c5532eb64d32882a826fd0eaf7b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BAP1/ASXL1 recruitment and activation for H2A deubiquitination
por: Danny D. Sahtoe, et al.
Publicado: (2016) -
Affinity-based proteomics reveals novel binding partners for Rab46 in endothelial cells
por: Lucia Pedicini, et al.
Publicado: (2021) -
A proteomics protocol to identify stimulation-induced binding partners dependent on a specific gene in mammalian cells
por: Junji Zhu, et al.
Publicado: (2021) -
USP48 restrains resection by site-specific cleavage of the BRCA1 ubiquitin mark from H2A
por: Michael Uckelmann, et al.
Publicado: (2018) -
Epigenetics Identifier screens reveal regulators of chromatin acylation and limited specificity of acylation antibodies
por: Leonie Kollenstart, et al.
Publicado: (2021)